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Abstract
Although the connection of microRNAs (miRNAs) to some diseases is well established, their involvement in chronic infections such as
Helicobacter pylori has received less attention. The aim was to compare miRNA expression profiling in patients with duodenal ulcer
(DU) due to H. pylori infection with that in infected patients without DU and in uninfected patients. The miRNA expression profile was
determined by microarrays in antral mucosal samples from well-characterized dyspeptic patients (n = 46). The most significant set of
miRNAs was subsequently analysed in an independent validation group of patients (n = 42). Transcripts for IL8, IL12p40, IL12p35 and
IL23p19, the signalling molecules MYD88, GATA6, SOCS2 and STAT6 and H. pylori virulence factors cagA and VacA were analysed.
Microarray experiments showed that 17 miRNAs were deregulated in the mucosa of H. pylori-infected patients. No significant differ-
ences were observed between normal and DU patients. PCR confirmed the up-regulation of miR-9, miR-146a, miR-155 and miR-650 and
the down-regulation of miR-96 and miR-204 in the independent validation set of patients. Importantly, miR-9, miR-96, miR-146a and
miR-650 expression was specific to chronic-active gastritis. H. pylori-infected patients showed higher levels of IL8 and IL12p40 mRNAs
and lower levels of GATA6 and SOCS2 mRNAs. The antral mucosa of patients with non-active or chronic-active gastritis showed signif-
icantly lower levels of GATA6, MYD88, SOCS2 and STAT6 mRNAs compared with patients without gastritis. The down-regulation of
these factors was not correlated with the expression of any of the validated miRNAs. The exact role of the miRNA changes observed
will require further study.
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Introduction
Helicobacter pylori has infected human beings for the past
58 000 years [1]. In most infected people, the bacterium acts
as a commensal organism inducing asymptomatic chronic
active gastritis that can last for life. In other cases, however,
it is responsible for a heavy toll of morbidity and mortality
as a consequence of peptic ulcers and gastric cancer.
It is a well-known fact that H. pylori-infected patients with
duodenal ulcer disease are at a lower risk of developing gas-
tric cancer than patients with gastric ulcerations [2]. Chronic
active gastritis in duodenal ulcer disease does not usually
lead to preneoplastic changes such as atrophy or metaplasia,
as it does in patients with gastric ulcer or non-ulcer dyspep-
sia. This wide individual response to infection has been
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attributed to environmental, host and bacterial virulence fac-
tors [3]. Despite intensive research in this field, clear risk or
disease-specific markers remain elusive.
Until recently, most of the known non-coding RNAs (ncR-
NAs) have been implicated in housekeeping functions in cells
[4]. But in the past few years, thousands of genes that pro-
duce ncRNA transcripts with no recognizable open reading
frame have been discovered [4,5]. MicroRNAs (miRNAs)
have received considerable attention because of their impact
on transcription output. miRNAs are a family of ncRNAs
involved in key biological processes such as differentiation,
development and cell growth [6].
miRNAs were first discovered in genetic screens of
Caenorhabditis elegans, and play a relevant role in the develop-
ment and growth of the worm [7]. This seminal discovery led
to the identification of the orthologous miRNA let-7 in human
cancer. Since then, numerous studies have focused on the
profiling of miRNAs in this setting [8]. Studies that analyse
gastric cancer have shown an altered profile of expression
(reviewed in [9,10]). Although the connection of miRNAs to
some diseases is well established, their involvement in the
response to bacterial infectious diseases has received much
less attention. In fact, only two studies have determined the
miRNA expression profile in the gastric mucosa of non-can-
cer patients infected with H. pylori [11,12]. Both studies were
performed in Asian populations and showed the deregulation
of miRNAs in H. pylori-infected patients.
The aim of this study was to identify and assess the micr-
oRNA expression pattern in H. pylori-infected patients with
duodenal ulcer disease.
Patients and Methods
Additional information about the reference standard, H. pylori
genotyping, PCR primers and molecular analyses can be
found in Supporting Information.
Patients
Outpatients sent to the Hospital de Sabadell for dyspeptic
symptoms from October 2006 to March 2010 were prospec-
tively recruited. Patients were contacted prior to the endos-
copy and were asked to participate. Before the endoscopy, the
patient signed the informed consent document in accordance
with the policy and guidelines of the Ethical Committee of our
institution. Those who accepted were instructed to avoid anti-
secretory drugs in the 2 weeks before the test. Patients unable
to stop antisecretory drugs, those who had received antibiot-
ics in the 4 weeks before the endoscopy and those with previ-
ous H. pylori treatment were excluded. During endoscopy,
antral biopsies were obtained for histology, rapid urease test
(RUT) and molecular studies. As gastric biopsy specimens can
show different levels of metaplasia or atrophy and miRNA pro-
filing is capable of identifying cell lineages and tissues [13,14],
patients with metaplasia or atrophy were excluded in order to
avoid potential confounding variables. Reference standard-neg-
ative patients with lymphoid aggregates were also excluded.
The study design is depicted in Fig. 1 and patients’ clinical
and demographic data are shown in Table 1.
Reference standard
Stringent patient selection criteria were used. A patient was
classified as being H. pylori positive if the results of the UBT,
RUT, H. pylori culture and histology were all positive.
Patients were defined as H. pylori negative if all tests were
negative.
H. pylori genotyping
PCR was used to determine H. pylori cagA status and to
genotype the vacA gene (signal s1/s2, intermediate i1/i2 and
midregion m1/m2 polymorphisms) as described previously
(detailed information on primer sequences and PCR condi-
tions is presented in Table S1). Isolates were classified as
high virulence (cagA+ VacA s1m1i1), low virulence (cagA-
VacA s2m2i2) or mixed.
High-throughput miRNA microarrays
miRNA profiling was performed with Human v1 MicroRNA
expression beadchips (Illumina Inc., San Diego, CA, USA).
FIG. 1. Study flow diagram.
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Reverse transcription and real-time PCR
Transcripts for interleukins IL8, IL23p19, IL12p35 and
IL12p40 and selected signalling molecules GATA6, MYD88,
SOCS2 and STAT6 were investigated (Table S2).
miR-9, miR-96, miR-98, miR-137, miR-146a, miR-155, miR-
196a, miR-204, miR-519e and miR-650 expression was
assessed by miRCURY LNATM Universal RT microRNA PCR
system (Exiqon, Vedbaek, Denmark) (Table S3).
Data and statistical analysis
The Illumina Beadchip raw data were imported to Bead-
Studio v3.2 (Illumina Inc.) and subsequently analysed as
detailed in Supplementary Methods. LinRegPCR v12.0 was
used to calculate the starting concentration per sample
(N0) [15]. Detailed information is provided in Supporting
Information.
Differences between groups were analysed using the
Mann–Whitney U-test or the Kruskal–Wallis H-test as
appropriate. Correlation was assessed by Spearman’s rho.
ROC curves were used to examine the diagnostic accuracy
of miRNAs. Statistical analyses were performed with SPSS
v19 (IBM Corporation, Armonk, NY, USA). Significance was
set at p <0.05.
Results
H. pylori infection alters miRNA expression in the antral
mucosa
Seventeen miRNAs were deregulated in the mucosa of
H. pylori-infected patients (p <0.05) (Table 2 and Fig. S1).
miR-96 was 1.5-fold down-regulated in patients with gastritis
(p 0.0144). Globaltest analyses (Table S4) showed no signifi-
cant differences with respect to sex, age, endoscopic diagno-
sis (normal vs. duodenal ulcer) or H. pylori virulence factors
(high virulence (cagA+ VacA s1m1i1) vs. low virulence (cagA-
VacA s2m2i2)).
Microarray data have been deposited in NCBI’s Gene
Expression Omnibus [16] (GEO Series accession number
GSE32174).
The expression of the selected miRNAs is confirmed in the
validation group of dyspeptic patients
miRNA RT-qPCR experiments performed on antral biopsies
from the independent validation group of dyspeptic patients
showed no statistical differences between normal and duode-
nal ulcer patients (Fig. 2). However, the increased expression
of miR-9, miR-146a, miR-155 and miR-650 (Fig. 3a) and
the down-regulation of miR-96 and miR-204 (Fig. 3b) was
confirmed.
The highest fold increases in miRNA expression related
to chronic active gastritis were for miR-650 (c. 10-fold), fol-
lowed by miR-146a (c. 6-fold) and miR-155 (c. 3-fold). miR-9,
TABLE 1. Demographic and clinical features of the dyspeptic patients in the training and validation sets
Training group Validation group
H. pylori status (reference standard) Negative Positive Negative Positive
N 9 37 22 20
Age (years) 46 ± 16.6 46 ± 14.4 47 ± 16.9 46 ± 13.9
Sex (male/female) 5/4 18/19 8/14 12/8
Endoscopic diagnosis N (%)
Normal 3 (33%) 17 (46%) 8 (36%) 4 (20%)
Duodenal ulcer/erosive duodenitis 0 17 (46%) 0 9 (45%)
Oesophagitis 5 (56%) 0 7 (32%) 1 (5%)
Hiatus hernia 1 (11%) 3 (8%) 4 (18%) 2 (10%)
Other 0 0 3 (14%) 4 (20%)
TABLE 2. Fold changes in miRNA expression as a result of
infection with H. pylori
Mean fold change Pa
Non-infected vs. infected
Up-regulated
hsa-miR-650 14.02 4.46E)09
hsa-miR-9* 4.32 2.36E)10
hsa-miR-9 2.79 1.29E)05
hsa-miR-519e 2.36 7.44E)13
hsa-miR-618 2.25 1.64E)05
hsa-miR-155 2.24 4.17E)13
hsa-miR-196a 2.08 8.65E)03
hsa-miR-801:9.1b 1.91 4.64E)03
hsa-miR-766 1.87 1.29E)05
hsa-miR-146a 1.69 7.44E)13
hsa-miR-566 1.67 3.14E)02
hsa-miR-671:9.1 1.54 2.04E)02
hsa-miR-146b-5p 1.53 5.41E)11
Down-regulated
hsa-miR-137 )1.56 1.20E)02
hsa-miR-190 )1.62 1.95E)06
hsa-miR-204 )1.64 3.01E)03
hsa-miR-502-5p )1.52 4.54E)03
Without gastritis vs. gastritis
Down-regulated
hsa-miR-96 )1.50 1.45E)02
aAfter False Discovery Rate correction for multiple testing.
bhsa-miR-801 was removed from miRBse because it appeared to be a fragment
of U11 spliceosomal RNA.
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miR-204 and miR-96 fold-changes in chronic active gastritis vs.
non-infected patients were 1.9, )2.0 and )2.4, respectively.
Non-active gastritis in the antrum is a common histologi-
cal diagnosis in dyspeptic patients. In our consecutive cohort
of dyspeptic patients (n = 425), 175 patients (41%) were
H. pylori negative. Among the H. pylori-negative cohort, 77%
of biopsies showed mild non-active gastritis according to the
pathologist’s report (unpublished observations). As non-
active gastritis is very common and this group was not analy-
sed in the microarray experiments, we decided to analyse a
group of 13 additional patients who were H. pylori negative
with non-active gastritis. RT-qPCR experiments showed no
differences in miRNA expression between H. pylori-negative
patients with and without non-active gastritis (Fig. 3a,b).
FIG. 2. Expression profile of the
selected miRNAs in H. pylori-infected
patients according to endoscopic find-
ings. (a) miR-9, miR-96, miR-146a, miR-
155, miR-204 and miR-650 expression
was not different between normal and
duodenal ulcer patients. (b) Expression
of the ‘housekeeping’ microRNA miR-98.
Mann–Whitney U-test. Box plots show
the 25th, 50th (median), 75th and range
(whiskers).
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Correlations for the validated miRNAs in relation to refer-
ence standard and gastritis activity
miR-146a and mirR-155 expressions were highly correlated
(Fig. 4) and independent of H. pylori status (reference nega-
tive without gastritis, rs = 0.9000 p <0.01) or gastritis activity
(non-active gastritis, rs = 0.7032, p <0.01; chronic active gas-
tritis, rs = 0.7108, p <0.01). Interesting results were also
found for the pair miR-155 and miR-204, which were corre-
lated in infected but not in non-infected patients
(rs = 0.6544, p <0.01) and in patients with active but not in
patients with non-active gastritis. miR-650 was correlated
with miR-146a and miR-155 in non-infected patients (miR-650
vs. miR-146a, rs = 0.8786, p <0.01; miR-650 vs. miR-155,
rs = 0.8284, p <0.01). Table S5 summarizes the coefficients
of correlations for all validated miRNAs in relation to gastri-
tis activity.
FIG. 3. Expression profile of the
selected miRNAs in dyspeptic patients
according to gastritis activity. (a) miR-9,
miR-146a, miR-155 and miR-650 are up-
regulated in patients with chronic active
gastritis but not in patients with non-
active gastritis. (b) miR-96 and miR-204
are down-regulated in patients with
chronic active gastritis but not in
patients with non-active gastritis. (c)
Gastritis activity has no effect on the
‘housekeeping’ miR-98. Kruskal-Wallis
H-test. Box plots show the 25th, 50th
(median), 75th and range (whiskers).
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IL8, IL12p40, IL12p35 and IL23p19 mRNA expression
We decided to determine IL8 expression because two of the
validated miRNAs from this study (miR-155 and miR-146a)
have been previously involved in its regulation [17–20]. Addi-
tionally, miR-155 also modulates the expression of IL-23 [21].
IL-23 is a heterodimer formed by IL23p19 and IL12p40 su-
bunits. The IL12p40 subunit is also shared to form the cyto-
kine IL-12 by combining with IL12p35.
Antral biopsies from H. pylori-infected patients showed
increased IL8 and IL12p40 mRNA expression (reference neg-
ative vs. positive: IL8, p <0.00001; IL12p40, p <0.0001)
(Fig. S3), which was significantly associated with gastritis
activity (non-active vs. chronic active gastritis: IL8, p <0.0001;
IL12p40, p 0.0018) (Fig. 5a). Patients with duodenal ulcer or
erosive duodenitis had a higher expression of IL8 mRNA
than infected non-ulcer subjects (p 0.0076).
In vivo IL8, IL12p40, IL12p35 and IL23p19 expression was
not correlated with the validated miRNAs (Table S6).
Expression of the signalling molecules MYD88, GATA6,
SOCS2 and STAT6
We determined MYD88 mRNA expression in our group of
H. pylori-infected patients because miR-9, miR-155 and miR-
146a are induced by Toll-like receptor-2 (TLR-2) and TLR-2
signals through MYD88 [18]. MYD88 mRNA expression was
not deregulated in H. pylori-infected patients (Fig. S3), and
miR-9, miR-155 and miR-146a expression was not correlated
with MYD88 expression (Table S6).
Previous microarray and immunochemistry experiments
[22] have revealed the mRNA and protein down-regulation
of the transcription factors GATA6 and STAT6 and the sup-
pressor of cytokine signaling-2 (SOCS2) in the antral mucosa
of H. pylori-infected patients. We therefore sought to corre-
late these findings with our miRNA signature. Our cohort of
patients confirms that the expression of GATA6 and SOCS2
is down-regulated in H. pylori-positive patients (reference
negative vs. positive: GATA6, p 0.0363; SOCS2, p 0.0060)
(Fig. S3). None of these genes, however, was associated with
gastritis activity (Fig. 5b) or the presence of duodenal disease
(not shown). GATA6, STAT6 or SOCS2 levels were not
correlated with the validated miRNAs (Table S6).
H. pylori virulence factors were associated with IL8 and
IL12p40 mRNA levels but not with validated miRNAs
CagA was present in 14 (70%) out of the 20 H. pylori isolates.
IL8 and IL12p40 mRNA levels were higher in the antral biop-
sies of patients infected with cagA+ strains (IL8, p 0.0340;
IL12p40, p 0.0262) (Fig. S4). Confirming our microarray
results, miR-9, miR-96, miR-98, miR-146a, miR-155, miR-204
and miR-650 expression in the H. pylori-infected patients was
FIG. 4. Correlation plots for the selected miRNAs in relation to
gastritis activity. rs, Spearman’s correlation coefficient.
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FIG. 5. mRNA gene expression of
selected interleukins (a), signalling mole-
cules (b) and the housekeeping gene (c)
in relation to gastritis activity. Kruskal-
Wallis H-test. Box plots show the 25th,
50th (median), 75th and range (whis-
kers).
CMI Lario et al. microRNA in duodenal ulcer disease E279
ª2012 The Authors
Clinical Microbiology and Infection ª2012 European Society of Clinical Microbiology and Infectious Diseases, CMI, 18, E273–E282
independent of the presence of cagA or vacA genotype
(Table S7).
The ratio miR-96/miR-155 shows the best diagnostic perfor-
mance
Among the individual miRNAs, only miR-650 showed high
performance with an AUC of 0.8659 (p <0.0001) (Table S8).
Sensitivities and specificities were improved when the ratio
between down-regulated (miR-204 and miR-96) and up-regu-
lated (miR-9, miR-146a, miR-155 and miR-650) miRNAs was
used. Among these, the ratio miR-96/miR-155 was the best
with AUC = 0.9665 (p <0.0001) with a sensitivity of 84.2%
and a specificity of 95.5%.
Discussion
The present study was designed to analyse miRNA expres-
sion in human H. pylori-infected patients with or without
duodenal ulcer disease, but with no histological diagnosis of
metaplasia or atrophy. This strict patient selection criterion
simplified microarray data analysis and interpretation,
because miRNA signatures are characteristic of cell lineages
and tissues [13]. Microarray results showed that miRNAs
are differentially expressed in the H. pylori-infected antrum.
In particular, 17 miRNAs were up-regulated and three were
down-regulated in the mucosa of H. pylori-infected patients.
The altered miRNA expression was not significantly associ-
ated with duodenal ulcer disease or with the presence of
H. pylori virulence factors cagA or vacA. We could confirm
the up-regulation of miR-9, miR-146a, miR-155 and miR-650
and the down-regulation of miR-96 and miR-204 in the inde-
pendent set of dyspeptic patients.
Thus far, only one report has described the miRNA pro-
file of H. pylori infection in non-cancer patients [11]. Our
miRNA signature is, however, significantly different. The only
factor shared by both studies is the down-regulation of miR-
204. Several explanations can be proposed for this discrep-
ancy. First, the population studied: the previous study was
performed in Japanese patients, whereas the present study
comes from a Western population. Apart from the different
genetic background of the populations analysed, it is widely
accepted that H. pylori East Asian strains are more virulent
than Western ones [23]. Second, our study reports the miR-
NA profiling of infected patients with strict criteria for
assuming the absence of infection and the presence of nor-
mal mucosa (i.e. without metaplasia or atrophy). Finally,
there are some methodological differences in the microarray
platforms used [24]. A major one is the preamplification step
performed prior to hybridization in our study. Nevertheless,
both studies were able to confirm their respective micro-
array results by RT-qPCR in a validation set of patients.
TLRs play an important role in maintaining mucosal
homeostasis [25]. After pathogen recognition, TLRs signal
through the adaptor molecule MYD88, which activates
downstream factors to coordinate the up-regulation of sev-
eral functionally distinct gene subsets. Moreover, MYD88-
deficient dendritic cells show impaired ability to mount local
gastric inflammatory responses after H. pylori infection [26].
miR-9, miR-146a and miR-155 are miRNAs regulated by TLR
in different cell types and some participate in the fine-tune
control of TLR signalling components [18]. miR-155 is
induced in cultured human T cells infected with H. pylori or
treated with the purified H. pylori components lipopolysac-
charide, VacA and c-glutamyl transpeptidase through the acti-
vation of the transcription factor Foxp3 and cAMP [27]. We
analysed MYD88 mRNA expression, and found no associa-
tion with H. pylori infection. This effect may be explained by
the recent observation that although MYD88 is a target of
miR-155, it is repressed by translational repression and not
by mRNA cleavage [20]. Further investigations will determine
whether this apparent discrepancy reflects a different regula-
tion of MYD88 by miR-155 in vivo (gastric mucosa) or in vitro
(cultured gastric cells). The same study reported in vitro inhi-
bition of IL8 by miR-155. In macrophages, miR-155 is a com-
mon target of a broad range of inflammatory mediators
including MYD88 and TRIF through TLR signalling and TNF-a
[28]. Additionally, miR-155 shows oncogenic properties [29].
The role of miR-155 in the induction and maintenance of
chronic active gastritis provoked by H. pylori and its progres-
sion to intestinal metaplasia, dysplasia and eventually gastric
cancer will be studied in the future.
Experiments performed with an acute monocytic leukae-
mia cell line stimulated with LPS have revealed that miR-146a
expression is induced by the NF-jB cascade activated after
the pathogen component has been recognized by the TLR
system [30]. Gastric epithelial cells infected with H. pylori
have shown that induced miR-146a down-regulates IRAK1
and TRAF6 proteins, participating in a negative loop that
restrains the excessive activity of the pathway [31]. Others,
by analysing epithelial cells and neutrophils isolated from cys-
tic fibrosis patients, have found that miR-146a is also impli-
cated in the regulation of IL8 [17]. IL-8 is a potent
neutrophil-activating chemokine released by gastric epithelial
cells infected with H. pylori [3]. The H. pylori-infected antral
biopsies from the present study showed increased IL8 and
IL12p40 mRNA expression. However, the set of validated
miRNAs did not correlate with IL8 or IL12p40 expression.
The cellular heterogeneity within antral biopsies may help
explain the lack of in vivo correlation between IL8 and
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miR-155 or miR-146a expression, because miRNA expression
is tightly regulated within cellular populations [13,14].
More striking was the up-regulation of miR-650 in our
dataset. To the best of our knowledge, miR-650 expression
has not been associated with epithelial physiology or immu-
nological response. The normal antral mucosa expressed
miR-650 at low levels and it was induced in infected patients
with chronic active gastritis. Very little is known about this
miRNA: it has been implicated in the development of distant
metastasis in gastric cancer patients [32] and is induced in
tumoural samples from colorectal cancer patients [33].
Previous microarray and immunochemistry experiments
[22] have demonstrated the mRNA and protein down-regu-
lation of GATA6, STAT6 and SOCS2 in the antral mucosa of
H. pylori-infected patients. Our results confirm the down-reg-
ulation of GATA6 and SOCS2 expression in H. pylori infec-
tion but we could not find a relationship between the
validated miRNAs and the mRNA levels of these genes.
H. pylori strains harbouring multiple virulence factors
(cagA+, VacA s1m1i1) are associated with increased gastric
mucosal inflammatory cell infiltration and increased gastric
epithelial injury [34]. Accordingly, our results show the up-
regulation of IL8 and IL12p40 in the antral biopsies of
patients infected with cagA+ strains but we were unable to
associate virulence factors with other variables. These results
might be limited by sample size; therefore, additional studies
will be required.
Finally, we examined the possibility of using the validated
miRNAs as novel surrogate markers for H. pylori infection.
The individual miRNA diagnostic performance was subopti-
mal, but by calculating the ratios between down-regulated
and up-regulated miRNAs the sensitivities and specificities
improved significantly, with sensitivities of c. 85% and speci-
ficities of c. 95%. The prospect that miRNAs might be used
as novel surrogate markers for H. pylori infection opens up
new possibilities for the early diagnosis of H. pylori infection,
especially in cases in which H. pylori detection is difficult, for
instance in patients with bleeding peptic ulcers [35].
The miRNA regulation reported by our study generates a
tentative miRNA signature for H. pylori infection, but in
order to obtain a definitive set of markers, we need to iden-
tify new, currently unknown miRNAs and demonstrate their
association with infectious diseases. Microarrays are high-
throughput and highly reproducible, but rely on the existing
knowledge of the sequences to be studied. Therefore, high-
throughput sequencing should be used to obtain complete
descriptions of tissue micro-transcriptome regulation.
In conclusion, our results show that a set of miRNAs are
deregulated during chronic gastric inflammation and that this
set may be useful as a surrogate marker for determining the
presence of H. pylori. The exact role of the miRNA changes
observed with the development of H. pylori complications
and, specifically, with the appearance of gastric neoplasm will
require further study.
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